FdaApplication

NDA 215498

Back to search

Identifiers

Properties

PropertyValue
applicant_nameIPSEN BIOPHARMACEUTICALS INC
application_typeNDA
approval_date2021-07-20

Products (4)

ProductActive ingredientStrengthDosage form
BYLVAYODEVIXIBAT0.2MGCAPSULE, PELLETS;ORAL
BYLVAYODEVIXIBAT0.4MGCAPSULE;ORAL
BYLVAYODEVIXIBAT0.6MGCAPSULE, PELLETS;ORAL
BYLVAYODEVIXIBAT1.2MGCAPSULE;ORAL

4 products